Navigating Regulatory Changes in Clinical Trials

Understanding the latest regulatory changes can be daunting, especially when you’re managing multiple trials. Recently, I had to update our documentation process in light of the new FDA guidelines on informed consent, and it took a considerable amount of time to ensure compliance without compromising efficiency. Has anyone else had to adapt their processes recently, and if so, what strategies worked for you?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​​​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‌‌‌​⁠‌‌‍⁠⁠‌‌‍‌​⁠‍​‌‍‌‍‌‌‌⁠‌⁠‌⁠‌​⁠‍‌​‍‍‌‍‍​‌​‌‌‌‌‍‌‌​‍‌‌​‍​‌​⁠​​‍​‍‌⁠⁠‌​

I totally get the struggle; it’s like trying to assemble IKEA furniture without the instructions. I recently streamlined our document review process by using checklists that incorporate the new guidelines — it’s saved us loads of time and headache. Have you tried anything similar?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‌⁠​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‌​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‍⁠​⁠‌‌‌​⁠​‌​‍​‌‍‌​‌‍‍‍‌‍​⁠‌⁠‌​‌‌‍‌‌‌‍‍‌‌‌‌​⁠‍​​⁠​‌‌‍​⁠‌‍‍‍‌⁠‍​​‍​‍‌⁠⁠‌

We’ve recently started using templates for our consent forms, which really sped up compliance. Have you tried that? It helped us align better with the new FDA guidelines! FDA Guidelines.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‍​⁠‌⁠​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‌​⁠​‌​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍⁠⁠‌‍‌⁠‌⁠‌‍‌⁠​⁠‌⁠​⁠​‍⁠‌‌‍⁠⁠‌​‍⁠‌‌‌⁠‌‍⁠⁠​⁠​‌‌‍‌‌‌​⁠‍‌​⁠​‌‌‍‍​‍​‍‌⁠⁠‌